Parkwalk Advisors Ltd

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009, anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth. Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Ian Broadhurst

Investor

Neil Cameron

Investment Director

Enrico D'Angelo

CFO

Cassie Doherty

Investment Director

Martin Glen

Investment Director

Tom Hopkins

Business Development Director

Alastair Kilgour

CIO

Claire Pardo

General Counsel

John Pearson

Investment Director

Kathy Samii

COO

ES

Emilie Syed

Senior Investment Associate

Alun Williams

Investment Director

Moray Wright

CEO

Karolina Zapadka

Investment Manager

283 past transactions

YASA Motors Ltd.

Series C in 2019
YASA was founded on the principle that small, light electric motors would play a growing role in meeting both the strict emissions targets being set globally in a wide range of industries and the requirement for greater efficiency through electrification. The Company was incorporated in 2009 based on a unique patented motor technology invented by the Company’s founder and CTO Dr Tim Woolmer whilst studying for his DPhil at Oxford University. The unique YASA motor technology is ideal for a range of mobile applications such as hydraulics replacement, power generation, traction and propulsion and hybridisation. YASA Motors manufactures a range of standard electric motors and generators based on our unique motor topology at our factory and Company Headquarters in Abingdon, Oxfordshire. The YASA-750, YASA-250 and YASA-400 products have been designed to be integrated into customers’ products in a range of markets and industries with minimal application engineering. In addition to our standard products, YASA has a design and development team dedicated to making bespoke motors for customers for medium-high volume applications.

Congenica Ltd.

Venture Round in 2020
Congenica Ltd. develops and operates clinical data solutions for genetic diagnosis worldwide. The company offers Sapientia, a clinical genomic analytics platform that provides integration of human DNA sequences with deep clinical phenotyping, enabling clinicians and researchers to provide actionable interpretation of genetic disease for patients. Its platform is also used for clinical diagnosis, prognosis, and research by clinicians and researchers. The company’s platform is also used in personalized medicine applications, such as creating disease registries, identifying patient populations for clinical studies, and discovering novel drug targets and biomarkers. Congenica Ltd. was incorporated in 2012 and is based in Hinxton, United Kingdom.
Creavo Medical Technologies Ltd. operates as a medical device company that develops imaging technologies. It offers a battery powered and portable medical device for the detection of heart-related problems in acute medical settings. Creavo Medical Technologies Ltd. was formerly known as Quantum Imaging Limited and changed its name to Creavo Medical Technologies Ltd. in September 2016. The company was incorporated in 2014 and is based in Coventry, United Kingdom.

PredictImmune Ltd

Series A in 2021
PredictImmune is developing pioneering tools for guiding treatment options in immune-mediated inflammatory diseases with the first product addressing Inflammatory Bowel Disease (both Crohn’s and ulcerative colitis). Based on world-leading research at Cambridge University, UK, they are developing a simple lab test, using a small blood sample, which accurately identifies patients at diagnosis who are at risk of experiencing severe, relapsing disease. These patients are likely to benefit from early biologics therapy. Physicians, patients and payors all recognise the value of such an approach to the management of Inflammatory Bowel Disease.

Kalium Diagnostics

Seed Round in 2020
Kalium Health Ltd designs, develops, and manufactures test for blood potassium concentration. The test equipment is based on a finger-prick blood test which will enable patients to seek treatment before complications arise and without the inconvenience, cost and delays associated with current testing methods. The company was formerly known as Kalium Diagnostics Ltd and changed its name to Kalium Health Ltd in July 2019. Kalium Health Ltd was incorporated in 2018 and is based in Cambridge, United Kingdom.

Arkivum

Series E in 2018
Arkivum delivers software, services and domain expertise for long term data management and digital preservation globally. We serve organisations around the world in data intensive and regulated markets. We make your long term data secure, accessible and usable for as long as you need it, providing assurance your data is where you need it, when you need it. Our domain expertise means we can guarantee 100% data integrity and best practice guidance for dealing with new compliance requirements as they are introduced. Our vendor neutral technology and no data lock-in means your data lives where you want it to and you own your data at all times. Arkivum delivers complete confidence in preserving, meeting complex compliance and regulatory requirements and creating business value from your data. Bringing your archived data to life.

Porotech

Seed Round in 2019
Porotech is a spin-out from the University of Cambridge. It mainly focuses on the development of wide-bandgap compound GaN semiconductors by applying material technologies and solutions to unleash the full potential of GaN to revolutionize the electronics industry. The company was co-founded by Dr. Tongtong Zhu, Dr. Yingjun Liu, and Prof. Rachel Oliver.

Zegami

Series A in 2017
Zegami is a data visualization platform designed to make data analysis accessible to everyone. The platform transforms data into actionable insight, using both structured and unstructured data, AI, and human pattern recognition. It helps users recognize patterns and discover insights to improve processes and strategies and create more accurate machine learning models. Founders Roger Noble and Stephen Taylor launched Zegami in 2016 in Oxford, Oxfordshire.
Surrey NanoSystems manufactures nanoscale materials for use in engineering and product applications. It offers Vantablack, a super-black coating that is applied to surfaces using vacuum-deposition technology, as well as for spraying and post-processing. Surrey NanoSystem’s Vantablack is used in various applications, such as stray light suppression, architectural lighting, aesthetic applications, calibration sources, sensors, telescopes, architecture, IR imaging systems, spectroscopy, automotive, cinematography optics, satellite calibration sources, camera lenses, and other applications. CEVP that began operation in 2006 became Surrey NanoSystems in December 2006, with its headquarters in Newhaven in the United Kingdom.

Symetrica

Venture Round in 2019
Symetrica Ltd. provides integrated radiation detection and identification technologies for custom organizations and government departments worldwide. Its technology for homeland security include gamma-ray detection and identification sub-systems; helium-3 neutron detector technology; and spectroscopic PVT detector systems. The company serves the military and homeland security markets. Symetrica Ltd. was founded in 2002 and is based in Southampton, United Kingdom with additional office in Maynard, Massachusetts.

Azul Optics Limited

Series B in 2017
Azul Optics is developing a device that can rapidly assess macular pigment density. Their device will be affordable, fast, easy-to-use and compact, making it easy to integrate macular pigment density screening into regular eye exams. Their goal is to introduce a technology that enables eye health professionals to rapidly assess macular pigments as an indicator of eye health.

PhoreMost Limited

Series B in 2021
PhoreMost Limited, a drug discovery company, engages in identifying new druggable targets for cancer and other unmet diseases. It develops Site-Seeker, a platform that systematically unmasks druggable sites in the human genome and links them to useful therapeutic functions in a live-cell context. The company was incorporated in 2014 and is based in Cambridge, United Kingdom.

Oxford Endovascular

Series A in 2021
Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel. This diverts the blood away from the aneurysm, allowing it to heal.

Mogrify

Series A in 2021
Mogrify® is a UK biotechnology company whose mission is to transform the development of ex vivo cell therapies, as well as pioneer a new class of in vivo reprogramming therapies. The Company has developed a proprietary direct cellular conversion platform that, for the first time, makes it possible to both systematically enhance the efficiency of stem cell-derived reprogramming and directly convert (transdifferentiate) mature cell types into other mature cell types (or states) without going through a pluripotent stem cell- or progenitor cell-state. Mogrify is applying its award-winning platform to engineer an evergreen and scalable source of cell types that exhibit efficacy and safety profiles necessary to develop ex vivo cell therapies or in vivo reprogramming therapies for indications of high unmet clinical need in oncology, ophthalmology and other disease areas. The platform is protected by the foundational patent application and a suite of additional patent applications covering improvements to the core platform and specific cell conversions. The Company is commercializing this via a business model of internal cell therapy development, co-development partnerships, and licensing of novel cell conversions to partners engaged in cell therapy development and regenerative medicine ($39 billion market USD by 2023). Mogrify was founded in 2016 and is headquartered in Cambridge, United Kingdom.

YASA Motors Ltd.

Series C in 2016
YASA was founded on the principle that small, light electric motors would play a growing role in meeting both the strict emissions targets being set globally in a wide range of industries and the requirement for greater efficiency through electrification. The Company was incorporated in 2009 based on a unique patented motor technology invented by the Company’s founder and CTO Dr Tim Woolmer whilst studying for his DPhil at Oxford University. The unique YASA motor technology is ideal for a range of mobile applications such as hydraulics replacement, power generation, traction and propulsion and hybridisation. YASA Motors manufactures a range of standard electric motors and generators based on our unique motor topology at our factory and Company Headquarters in Abingdon, Oxfordshire. The YASA-750, YASA-250 and YASA-400 products have been designed to be integrated into customers’ products in a range of markets and industries with minimal application engineering. In addition to our standard products, YASA has a design and development team dedicated to making bespoke motors for customers for medium-high volume applications.

Legislate Technologies

Seed Round in 2023
Legislate Technologies is transforming the way people enter contracts and negotiate terms in a transparent, efficient and fair way.

Cytora

Series A in 2017
Cytora transforms underwriting for commercial insurance. The Cytora Risk Engine uses artificial intelligence to learn the patterns of risks over time, enabling insurers to underwrite more efficiently and deliver fairer prices to customers. The company's goal is to raise the insurance industry to a new standard where insurance is fast and built on a foundation of tractable data. The company's products allow insurers to enhance underwriting profitability. Cytora was founded on 2014 and is headquartered in London.
Surrey NanoSystems manufactures nanoscale materials for use in engineering and product applications. It offers Vantablack, a super-black coating that is applied to surfaces using vacuum-deposition technology, as well as for spraying and post-processing. Surrey NanoSystem’s Vantablack is used in various applications, such as stray light suppression, architectural lighting, aesthetic applications, calibration sources, sensors, telescopes, architecture, IR imaging systems, spectroscopy, automotive, cinematography optics, satellite calibration sources, camera lenses, and other applications. CEVP that began operation in 2006 became Surrey NanoSystems in December 2006, with its headquarters in Newhaven in the United Kingdom.

Riverlane

Seed Round in 2021
Riverlane is the most advanced quantum computing software developer

Psyomics

Series B in 2019
PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.

Inkpath Limited

Series A in 2019
Inkpath Limited develops a skill tracker software platform that enables university students and administrators to plan and track their personal and professional development. The platform enables users to monitor development, set goals, manage courses, and track attendance and feedback. The company's smartphone application directs users to training and development opportunities relevant to their desired path, allowing them to track their progress, export it for a CV, share it with other online platforms, and get constant, data-driven feedback. The company was founded in 2015 and is based in Thame, United Kingdom.

Mind Foundry Limited

Seed Round in 2019
Mind Foundry is an Oxford University AI company, founded by Professors Stephen Roberts and Michael Osborne, pioneers in the field of AI and Machine Learning. With a deep understanding of how important these technologies are to our future, the mission of Mind Foundry is to create a future where AI and Humans work together to solve the world’s most important problems. Mind Foundry has developed technology and products that help people bring machine learning closer to their work. Our platform is a new type of Machine Learning that is powerful enough to be trusted by experts and easy enough to be used by people throughout your organization. Built upon a foundation of scientific principle, organisations use Mind Foundry to empower their teams in entirely new ways.

Cisiv

Series C in 2015
Cisiv Ltd provides novel technology solutions to global pharmaceutical, biotech companies, research organizations, and academia. It offers Baseline Plus, a data capture platform for non-interventional studies that allows sponsors and CROs to run complex large-scale multi-national studies in a simple and cost-effective way. The company’s Baseline Plus creates a communication platform for study groups for supporting data entry and improving data quality and work flow; offers online community features and translation capabilities; and allows researchers and medical professionals to extract meaningful patient data. Cisiv Ltd was incorporated in 1995 and is based in Kingston upon Thames, United Kingdom.

Oxford Endovascular

Series B in 2021
Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel. This diverts the blood away from the aneurysm, allowing it to heal.

GeoSpock Ltd.

Series B in 2019
GeoSpock Limited develops data indexing platform, which provides analytics, builds insight, and enables predictions across space and time. The company's products include GeoSpock DB Discovery and GeoSpock DB Enterprise that offers cloud-based database service for all location tagged information and enables the user to carry out dynamic data fusion and query complex data for performance analytics. It powers any location based service from real time tracking of entire logistics fleets to local taxi finding application. The company was incorporated in 2013 and is based in Cambridge, United Kingdom with additional offices in Tokyo, Japan; and Singapore.

MoA Technology Ltd.

Series B in 2022
MoA Technology Limited is a plant genetics company spun out from the University of Oxford. Professor Liam Dolan, FRS, has developed an innovative approach for the discovery of agricultural technologies that will enable farmers to produce healthy food from sustainable crop systems.

Lumenisity

Series C in 2021
Lumenisity is developing advanced cable solutions to address the need for massive bandwidth increases in high capacity communications systems. Formed in 2016 to commercialise the world class R&D in optical fibre technologies from the University of Southampton, the company is well funded by a consortium of industrial and private investors and is currently building an extensive team and infrastructure.

Tangentix Limited

Series A in 2013
Tangentix, a UK-based Sheffield, UK-based startup that is exploring the use of 3D graphics compression.

1715Labs

Seed Round in 2020
1715Labs is a company being established to commercialise Zooniverse technology.

PetMedix

Series B in 2021
PetMedix is a development stage veterinary biopharmaceutical company based in Cambridge, UK. they are using the highest quality science to make the therapies their pets need and deserve, keeping them healthier, happier, and for longer. Building on more than thirty years of world-leading innovation and human drug development, they are applying the cutting edge of science to bring breakthroughs for the animals they love and care for.

AccelerComm

Series B in 2023
AccelerComm Ltd provides Forward Error Correction (FEC) or channel coding solutions. It provides error correction decoder for markets, such as 3G and 4G Mobile handsets and base stations, satellite standards, and communication applications. The company’s products, include Polar, 3GPP Compliant Encoding/Decoding Chain; Turbo Decoder; and LDPC, 3GPP Compliant LDPC Encoding/Decoding Chain. AccelerComm Ltd was incorporated in 2016 and is based in Southampton, United Kingdom.

Clean Air Power Limited

Venture Round in 2013
Clean Air Power has pioneered the move towards using natural gas to power vehicles by developing Dual-Fuel™ technologies that guarantee diesel engine performance, with significant cost savings and low carbon emissions. Diesel trucks can run on natural gas, a cleaner, greener and cheaper way to move freight. Clean Air Power has pioneered its innovative Dual Fuel™ technology – and complementary component systems – that deliver lower fuel costs for operators and no compromise on performance for drivers. With the added benefit of significantly lower tailpipe CO2 and air quality emissions.

Perpetuum Ltd.

Series C in 2014
Perpetuum Ltd. engineers, manufactures, and commercializes electromagnetic vibration harvesting micro generators. It offers battery-free vibration energy harvesters and wireless sensor nodes for passenger and freight applications; and industrial vibration energy harvesters and industrial wireless sensor nodes that are used for process monitoring and equipment condition-based monitoring in industrial environments. The company also provides wireless transmitters and programmable measurement nodes. It serves rail, oil and gas, chemicals, power generation, water and wastewater treatment, and process manufacturing industries. Perpetuum Ltd. was incorporated in 2004 and is based in Southampton, United Kingdom.

Heterogeneous

Series A in 2022
Sano Genetics is a user-centric genetic data marketplace that connects individuals directly to the research world. It act as ethical brokers to facilitate a direct connection between you and research institutions. The company was founded in 2017 and is headquartered in Cambridge.

Healthera

Seed Round in 2016
Healthera Ltd. develops and provides an application for reminding medicine from the local pharmacy. It offers Healthera, a pharmacy-integrated medication application that offers a professional, personal, and automatic notification system through partner pharmacies and builds a channel of communication that addresses medical issues. The company’s application is used for smart prescription labelling, automatic scheduling, knowing the health condition, professional advice, and talking to the pharmacist. Its application serves patients and pharmacies. Its products also include Serket, a platform that ensures medication adherence. Healthera Ltd. was formerly known as Serket Technology Ltd. and changed its name to Healthera Ltd. in May 2016. The company was incorporated in 2015 and is based in Cambridge, United Kingdom.

Bramble Energy Ltd.

Series B in 2022
Bramble Energy Ltd. designs, develops, and manufactures printed circuit board (PCB) fuel cell – the PCBFC, which helps the PCB industry in the manufacturing of proton exchange membrane fuel cells (PEMFCs). The company's products include Bramble Energy 20 W PCBFC stack, Bramble Energy 500W PCBFC stack, Bramble Energy 5kW PCBFC stack, and Bramble Energy custom design PCBFC. It serves to stationary, portable, and automotive and mobility sectors. The company was incorporated in 2015 and is based in London, United Kingdom.

Arkivum

Series F in 2020
Arkivum delivers software, services and domain expertise for long term data management and digital preservation globally. We serve organisations around the world in data intensive and regulated markets. We make your long term data secure, accessible and usable for as long as you need it, providing assurance your data is where you need it, when you need it. Our domain expertise means we can guarantee 100% data integrity and best practice guidance for dealing with new compliance requirements as they are introduced. Our vendor neutral technology and no data lock-in means your data lives where you want it to and you own your data at all times. Arkivum delivers complete confidence in preserving, meeting complex compliance and regulatory requirements and creating business value from your data. Bringing your archived data to life.

Paragraf Ltd.

Series B in 2022
Paragraf Ltd. is a graphene technology development company that focuses on the production of two-dimensional materials. The company develops graphene-based electronic devices; green energy generation devices, such as solar PV cells; and sensors. The company was incorporated in 2015 and is based in Somersham, United Kingdom.

Covatic Ltd

Series A in 2017
Covatic is a Birmingham and Oxford start-up exploring the use of mobile based algorithms to bring smart personalisation to apps. We are a small team of enthusiastic problem solvers, who are always looking for like-minded people to join us and take our products to the next level.

Zentraxa

Seed Round in 2021
Zentraxa’s proprietary technological platform, Zentide, combined with our extensive technical know-how allows us to push the boundaries of what can be achieved with synthetic biopolymers. We specialise in the design, production and testing of complex novel peptides and, as a result of our Zentide platform, can circumvent previously existing bio-design limits imposed by conventional peptide synthesis, with one universal process.

ROADMap Systems

Series A in 2016
ROADMap Systems Limited owns and operates technology company. It offers wavelength selective switches (WSSs) technology for fibre optic communication networks. These switches are used to create reconfigurable optical add/drop multiplexers (ROADMs). It also offers telecom and datacom applications to overcome challenges related to data rate, fibre management, power requirements, and network costs. The company was founded in 2013 and is headquartered in Cambridge, United Kingdom.

Entia

Series A in 2019
Entia Ltd offers a medical device, which improves access to blood tests. It includes spanning design, engineering, quality assurance, business development, and innovation services. The company offers aptus a haemoglobin and haematocrit-testing device, which helps in health screening, blood donor screening, maternal and child health, nutrition, and sport fields. It also provides affinity for cancer patients to monitor their blood counts at home, which reduces risk of infection and avoid trips to hospitals. The company was founded in 2014 and is based in London, United Kingdom.

Psyomics

Venture Round in 2022
PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.

Quethera

Seed Round in 2015
Quethera is a gene therapy company dedicated to improving the future treatment of common blinding eye diseases. Our initial focus is on developing therapies to reduce progressive visual loss in glaucoma and other conditions affecting the optic nerve. Quethera is working alongside world leaders in the glaucoma field to design clinical trials capable of examining the efficacy and safety of novel therapies in patients who lose parts of their visual field at an accelerated rate (fast-progressors). The company has expertise in gene therapeutic design and development sufficient to progress its pipeline through preclinical testing and into clinical development.

Salunda Limited

Venture Round in 2016
Salunda develops robust, contactless sensors for use in very harsh environments. The company’s sensor technology detects position and speed, and measures the composition of fluids. Salunda has developed patented, contactless sensor technology for monitoring machinery in very harsh environments. Sensors scan components such as pistons, rotors and seals for wear and failure. A profile of the component surface can be recorded with sensitivities of as little as tens of microns. Sensors can warn of imminent failure by detecting cracks, eccentric motion, ‘orbiting’, axial shift or vibration. The oil industry requires accurate, repeatable measurement of the separation of water, oil and gas. Salunda is developing reliable, inline sensors that measure the water content of crude oil, contamination and actual fluid level in the presence of bubbles and froth. OEM components based on patented technologies are available for open-bore water cut and multiphase flow application.

YASA Motors Ltd.

Series C in 2014
YASA was founded on the principle that small, light electric motors would play a growing role in meeting both the strict emissions targets being set globally in a wide range of industries and the requirement for greater efficiency through electrification. The Company was incorporated in 2009 based on a unique patented motor technology invented by the Company’s founder and CTO Dr Tim Woolmer whilst studying for his DPhil at Oxford University. The unique YASA motor technology is ideal for a range of mobile applications such as hydraulics replacement, power generation, traction and propulsion and hybridisation. YASA Motors manufactures a range of standard electric motors and generators based on our unique motor topology at our factory and Company Headquarters in Abingdon, Oxfordshire. The YASA-750, YASA-250 and YASA-400 products have been designed to be integrated into customers’ products in a range of markets and industries with minimal application engineering. In addition to our standard products, YASA has a design and development team dedicated to making bespoke motors for customers for medium-high volume applications.

BOXARR

Seed Round in 2015
BOXARR is a software company headquartered in the UK, operating internationally through a global network of Alliance Partners. The BOXARR platform enables organisations to effectively manage their complexity, mitigate risks, and identify opportunities to prosper. The BOXARR platform is the leading solution for Inter-dependent Systems Management.

Cytoseek

Seed Round in 2021
CytoSeek's mission is to use cell membrane augmentation technology to unlock the potential of next generation of advanced therapies. We are a spinout company from the University of Bristol. Our novel cell membrane augmentation technology enables us to add new functionalities to cell therapies including tissue specific targeting and enhanced cell survivability. CytoSeek is engaged in proof of principle studies to demonstrate enhancement of cell therapies for cancer, heart disease, osteoarthritis and diabetic wound healing. We are looking to partner with cell therapy companies to bring these products to the clinic and ultimately enhance human health.

Nozzle Limited

Series A in 2019
Nozzle Limited offers artificial intelligence consultancy services. The company offers data operations tech stacks and machine learning operations tech stacks. It offers set up, trial, AI feasibility, and production services. The company also develops Nozzle, which enables to increase return on ad spend and total Amazon sales and reduce time on campaigns. Nozzle Limited was formerly known as MediaGamma Limited and changed its name to Nozzle Limited in May 2020. The company was incorporated in 2014 and is headquartered in London, United Kingdom. As of April 15, 2020, Nozzle Limited operates as a subsidiary of Beeswax, Inc.

Entia

Series A in 2021
Entia Ltd offers a medical device, which improves access to blood tests. It includes spanning design, engineering, quality assurance, business development, and innovation services. The company offers aptus a haemoglobin and haematocrit-testing device, which helps in health screening, blood donor screening, maternal and child health, nutrition, and sport fields. It also provides affinity for cancer patients to monitor their blood counts at home, which reduces risk of infection and avoid trips to hospitals. The company was founded in 2014 and is based in London, United Kingdom.

Stent Tek

Series A in 2022
Pathfinder Medical is developing a novel electronic guidance system that will enable clinicians to connect blood vessels in a minimally invasive way. This platform technology has a variety of clinical applications such as bypassing peripheral blockages and in vascular access creation for dialysis patients, which represents a £1.6b yearly market.

NoBACZ

Seed Round in 2020
NoBACZ is pioneering a novel, new precision bandaging platform for the veterinary and human market. The company specializes in rapid set liquid barriers.

Paragraf Ltd.

Series A in 2019
Paragraf Ltd. is a graphene technology development company that focuses on the production of two-dimensional materials. The company develops graphene-based electronic devices; green energy generation devices, such as solar PV cells; and sensors. The company was incorporated in 2015 and is based in Somersham, United Kingdom.

MoA Technology Ltd.

Seed Round in 2017
MoA Technology Limited is a plant genetics company spun out from the University of Oxford. Professor Liam Dolan, FRS, has developed an innovative approach for the discovery of agricultural technologies that will enable farmers to produce healthy food from sustainable crop systems.

Heterogeneous

Seed Round in 2022
Sano Genetics is a user-centric genetic data marketplace that connects individuals directly to the research world. It act as ethical brokers to facilitate a direct connection between you and research institutions. The company was founded in 2017 and is headquartered in Cambridge.
Quantum Motion Technologies Limited develops technology platform using the array of qubits to create quantum computing architectures. The company’s quantum computing technology able to tackle situations in fields of chemistry, medicine, and artificial intelligence. Quantum Motion Technologies Limited was incorporated in 2017 and is based in Leeds, United Kingdom.

Microsaic Systems plc

Venture Round in 2013
Microsaic Systems plc is a high technology company developing and marketing next generation mass spectrometry instruments.

Nozzle Limited

Series A in 2021
Nozzle Limited offers artificial intelligence consultancy services. The company offers data operations tech stacks and machine learning operations tech stacks. It offers set up, trial, AI feasibility, and production services. The company also develops Nozzle, which enables to increase return on ad spend and total Amazon sales and reduce time on campaigns. Nozzle Limited was formerly known as MediaGamma Limited and changed its name to Nozzle Limited in May 2020. The company was incorporated in 2014 and is headquartered in London, United Kingdom. As of April 15, 2020, Nozzle Limited operates as a subsidiary of Beeswax, Inc.

Paragraf Ltd.

Series A in 2022
Paragraf Ltd. is a graphene technology development company that focuses on the production of two-dimensional materials. The company develops graphene-based electronic devices; green energy generation devices, such as solar PV cells; and sensors. The company was incorporated in 2015 and is based in Somersham, United Kingdom.

OxSyBio

Series A in 2018
OxSyBio Ltd. develops 3D printing techniques to produce tissue-like and functional tissues for medical research and clinical applications. It develops printing tissue-like materials comprised of 3-dimensional networks of lipid monolayer aqueous droplets that are used for conducting electrical signals along pre-defined pathways, and self-folding to form complex geometries. The tissues can be used in the clinic for organ repair or replacement. The company was founded in 2014 and is based in London, United Kingdom.

Bibliotech

Series A in 2022
BibliU is a digital educational service that enables university students to search across thousands of textbooks and monographs, engage with each other and their professors, making learning far more effective.

Cytora

Series A in 2017
Cytora transforms underwriting for commercial insurance. The Cytora Risk Engine uses artificial intelligence to learn the patterns of risks over time, enabling insurers to underwrite more efficiently and deliver fairer prices to customers. The company's goal is to raise the insurance industry to a new standard where insurance is fast and built on a foundation of tractable data. The company's products allow insurers to enhance underwriting profitability. Cytora was founded on 2014 and is headquartered in London.

Gripable

Series A in 2022
Gripable is develops simple digital therapy tools, combining them with mobile games, motivating physically impaired patients. GripAble began during our research with stroke patients struggling to use their hands for simple activities. Everyday tasks - getting dressed in the morning, holding a glass of water - are a huge frustration for them. This is the reality for over 500 million people around the world suffering with impaired arm mobility. These patients need, and want, more therapy. GripAble's first product is a highly sensitive, portable hand-grip that connects wirelessly with a mobile-based app, allowing patients to play our fun therapy games. It is designed for low-cost, easy-access assessment and therapy of hand and arm disability, providing increased engagement and allowing for self-training in hospitals and at home.

SERG Technologies

Seed Round in 2022
SERG Technologies is re-defining the way we interact with technology by creating reliable and functional wearables that can be used for activity tracking, monitoring health and fitness, and gesture recognition for smart devices. Our unique sensors detect tiny, subconscious movements that indicate a wearer’s intent, we turn these into control signals for everything from TV’s to smart prosthetics, resulting in almost instant response times. We are also developing new tools to allow Parkinson's patients to track their symptoms, providing vital new information to their doctors, leading to long term improvements to the efficacy their treatment. SERG was founded to make the gesture control of technology accessible for everyone and easier to use than ever before.

Carbometrics

Seed Round in 2021
Carbometrics is a specialist chemistry company .Our core competency is the design, synthesis and derivatisation of highly selective and robust carbohydrate-binding molecules. Our technology is based on over 20 years of cutting-edge research pioneered by Professor Anthony Davis’ group at the University of Bristol. Carbometrics’ goal is to exploit our GBM technology to realise a highly robust and accurate glucose sensing platform that can be used to create a market-leading Continuous Glucose Monitoring (CGM) solution. The company was set up after the founders sold their first company Ziylo to Novo Nordisk, which is using the same platform to develop smart insulins.

Psyomics

Series A in 2016
PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.
Cambridge CMOS Sensors (CCS) is an industry leader in sensor technology and a leading manufacturer of sensor solutions and components for monitoring air quality, including hazardous gases and Volatile Organic Compounds (VOCs). Founded in 2008 as a spin-off from Cambridge University, we are revolutionising environmental sensing for health and well-being through a new generation of semiconductor-based sensors. Our technology offers a radical step change in performance, with significantly lower power consumption, ultra-fast response time, embedded intelligence and ultra-small form factor.

ReInnervate

Series B in 2011
ReInnervate Limited, a biotechnology company, engages in the development of enabling technologies that facilitate research into cell growth and function in vitro, primarily in the field of stem cell biology. Its technologies control the differentiation of stem cells and the formation of specific tissue types, as well as offers tools to develop diagnostics and treatments for neuro-degenerative diseases. The company was founded in 2002 and is based in Durham, the United Kingdom.

Active Inspiration Technologies

Venture Round in 2015
Award winning digital health platform called "Fuell" with a goal of getting Employees to achieve weekly health goals. Data Collection from wearables Engagement through self service and sponsored challenges Loyalty and Monetisation through tokens Low cost monthly subscription with data driven outcomes for Employers, Brands and Organisations.

Gripable

Seed Round in 2021
Gripable is develops simple digital therapy tools, combining them with mobile games, motivating physically impaired patients. GripAble began during our research with stroke patients struggling to use their hands for simple activities. Everyday tasks - getting dressed in the morning, holding a glass of water - are a huge frustration for them. This is the reality for over 500 million people around the world suffering with impaired arm mobility. These patients need, and want, more therapy. GripAble's first product is a highly sensitive, portable hand-grip that connects wirelessly with a mobile-based app, allowing patients to play our fun therapy games. It is designed for low-cost, easy-access assessment and therapy of hand and arm disability, providing increased engagement and allowing for self-training in hospitals and at home.

Psyomics

Venture Round in 2020
PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.

NU QUANTUM LTD

Seed Round in 2020
NU QUANTUM LTD develops quantum photonics hardware, photon sources and detectors, and quantum cryptography systems. It provides nano-engineered materials for generation of light at the quantum level and ultra-sensitive detection of light; fundamental algorithms and protocols for the generation of secure keys; and quantum encryption links for exchanging cryptographic keys. The company was founded in 2018 and is based in Cambridge, United Kingdom.
Cambridge Touch Technologies, Ltd. develops next-generation UltraTouch technology for smart devices such as smartphones, tablets, automotive and industrial applications. Combining a proprietary AI engine running sophisticated signal processing algorithms with an advanced Piezoelectric Force Film, UltraTouch enables the world’s simplest all-in-one touch and force sensor architecture that delivers superior functionality at lower cost, and scales to all device sizes and shapes (including curved and foldable)

Echion Technologies

Series A in 2021
Echion Technologies Ltd. develops and manufactures Li-ion batteries for the mobile devices manufacturing industry and automotive industry. The company was founded in 2017 and is based in Cambridge, United Kingdom.

GeoSpock Ltd.

Venture Round in 2019
GeoSpock Limited develops data indexing platform, which provides analytics, builds insight, and enables predictions across space and time. The company's products include GeoSpock DB Discovery and GeoSpock DB Enterprise that offers cloud-based database service for all location tagged information and enables the user to carry out dynamic data fusion and query complex data for performance analytics. It powers any location based service from real time tracking of entire logistics fleets to local taxi finding application. The company was incorporated in 2013 and is based in Cambridge, United Kingdom with additional offices in Tokyo, Japan; and Singapore.

Bibliotech

Seed Round in 2017
BibliU is a digital educational service that enables university students to search across thousands of textbooks and monographs, engage with each other and their professors, making learning far more effective.
First Light Fusion Limited discovers advanced implosion processes for electricity generation. First Light Fusion Limited was formerly known as Oxyntix Ltd. and changed its name to First Light Fusion Limited in June 2014. The company was founded in 2011 and is based in Begbroke, United Kingdom.

PredictImmune Ltd

Series B in 2019
PredictImmune is developing pioneering tools for guiding treatment options in immune-mediated inflammatory diseases with the first product addressing Inflammatory Bowel Disease (both Crohn’s and ulcerative colitis). Based on world-leading research at Cambridge University, UK, they are developing a simple lab test, using a small blood sample, which accurately identifies patients at diagnosis who are at risk of experiencing severe, relapsing disease. These patients are likely to benefit from early biologics therapy. Physicians, patients and payors all recognise the value of such an approach to the management of Inflammatory Bowel Disease.

Sphere Fluidics

Series A in 2013
Sphere Fluidics Limited is a new Life Sciences company which has developed unique products for use in single cell analysis and characterisation and provides collaborative R&D services in this area.

Fuel3D

Series A in 2022
A handheld 3D scanning system delivering high quality 3D shapes and colour captures for a range of creative applications

Intelligent Ultrasound

Venture Round in 2017
Intelligent Ultrasound develops software that improves the quality, reliability and diagnostic power of medical ultrasound – the most widely used medical imaging tool in the world. The company’s products make ultrasound easier to use and help hospitals to provide a consistently high-quality ultrasound imaging service, thereby minimising the risk of wrong or missed diagnoses. It's first product has been shown to improve rates of diagnosis in ultrasound scans of the heart by more than 40%.

Kvasir Analytics

Seed Round in 2021
Kvasir Analytics is an AI knowledge management software company.

PetMedix

Series A in 2019
PetMedix is a development stage veterinary biopharmaceutical company based in Cambridge, UK. they are using the highest quality science to make the therapies their pets need and deserve, keeping them healthier, happier, and for longer. Building on more than thirty years of world-leading innovation and human drug development, they are applying the cutting edge of science to bring breakthroughs for the animals they love and care for.

Fuel3D

Venture Round in 2017
A handheld 3D scanning system delivering high quality 3D shapes and colour captures for a range of creative applications
Oxford Photovoltaics Limited develops and commercializes thin-film perovskite solar cells that are printed directly onto silicon solar cells, CIGS solar cells, or glass. Oxford Photovoltaics Limited has a strategic partnership with Meyer Burger Technology Ltd. The company was incorporated in 2010 and is based in Oxford, United Kingdom.

Covatic Ltd

Seed Round in 2017
Covatic is a Birmingham and Oxford start-up exploring the use of mobile based algorithms to bring smart personalisation to apps. We are a small team of enthusiastic problem solvers, who are always looking for like-minded people to join us and take our products to the next level.

DiffBlue

Seed Round in 2022
Diffblue is changing the way software is developed using Artificial Intelligence (AI). Diffblue Cover, the company’s first product, automatically generates tests for Java code to enable development teams to deliver higher quality software, faster. Diffblue’s technology is developed by its team of leading experts in AI, software verification and synthesis, and customers include Goldman Sachs and Amazon Web Services. Diffblue is backed by Oxford University, Oxford Sciences Innovation and Goldman Sachs and is headquartered in Oxford, UK.

PredictImmune Ltd

Series A in 2017
PredictImmune is developing pioneering tools for guiding treatment options in immune-mediated inflammatory diseases with the first product addressing Inflammatory Bowel Disease (both Crohn’s and ulcerative colitis). Based on world-leading research at Cambridge University, UK, they are developing a simple lab test, using a small blood sample, which accurately identifies patients at diagnosis who are at risk of experiencing severe, relapsing disease. These patients are likely to benefit from early biologics therapy. Physicians, patients and payors all recognise the value of such an approach to the management of Inflammatory Bowel Disease.

MoA Technology Ltd.

Series A in 2019
MoA Technology Limited is a plant genetics company spun out from the University of Oxford. Professor Liam Dolan, FRS, has developed an innovative approach for the discovery of agricultural technologies that will enable farmers to produce healthy food from sustainable crop systems.

Porotech

Seed Round in 2021
Porotech is a spin-out from the University of Cambridge. It mainly focuses on the development of wide-bandgap compound GaN semiconductors by applying material technologies and solutions to unleash the full potential of GaN to revolutionize the electronics industry. The company was co-founded by Dr. Tongtong Zhu, Dr. Yingjun Liu, and Prof. Rachel Oliver.

Lumenisity

Venture Round in 2020
Lumenisity is developing advanced cable solutions to address the need for massive bandwidth increases in high capacity communications systems. Formed in 2016 to commercialise the world class R&D in optical fibre technologies from the University of Southampton, the company is well funded by a consortium of industrial and private investors and is currently building an extensive team and infrastructure.

Undo

Series B in 2018
Undo Ltd. develops debugging tools for developers, software architects, product managers, and field application engineers. It offers live recorder that records and replay the execution of software, records the programming errors, debug the recordings, and integrates and automates container platform. The company also provides UndoDB, an interactive reversible debugger for C/C++ on Linux and Android. It serves data management, networking, electronic design automation, and financial industries. Undo Ltd. was incorporated in 2005 and is based in Cambridge, United Kingdom with an additional office location in San Francisco, California.

TheySay

Series B in 2014
TheySay, an Oxford University, UK-based sentiment analysis start-up. TheySay’s core product is AffectR, a platform that employs a deep linguistic approach allowing it to interpret sentiment computationally.It can extract the sentiment portrayed towards a specified entity in a given passage of text.
Cambridge Touch Technologies, Ltd. develops next-generation UltraTouch technology for smart devices such as smartphones, tablets, automotive and industrial applications. Combining a proprietary AI engine running sophisticated signal processing algorithms with an advanced Piezoelectric Force Film, UltraTouch enables the world’s simplest all-in-one touch and force sensor architecture that delivers superior functionality at lower cost, and scales to all device sizes and shapes (including curved and foldable)

Brainomix Limited

Series B in 2021
Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providing real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.

Horizon Discovery Group plc

Venture Round in 2013
Horizon Discovery Group PLC is a UK life science company that uses gene editing and gene modulation platforms to produce cells, applying them in research and clinical applications that advance human health. The Company’s gene editing and gene modulation platform, are able to alter almost any DNA sequence or RNA transcription, has generated a catalogue of over 1,000,000 cell and reagent products that help researchers recapitulate the genetic and protein anomalies found in diseases like cancer. These models have been adopted by c12, 000 organizations to better understand of the predictors and drivers of disease and drug response, and by Horizon in a range of services offered to customers, as well as in the Company’s own research R&D pipeline.

Bonnet Ltd.

Seed Round in 2021
Bonnet aims to reduce the headache associated with drivers having to register separately for individual public charging networks to charge their car. Instead, we provide a subscription service for drivers and businesses that allows them to use any public charger with just one account.